R. Sharma

Phase I first-in-human study of the polo-like kinase-1 selective inhibitor, GSK461364, in patients with advanced solid tumors.

D. Smith, D. Barker, D. Olmos, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Aromatic l-amino acid decarboxylase deficiency

C. Chiriboga, D. D. De Vivo, R. Pons, 2004, Neurology.

Comparison of the utility of Cocaine- and Amphetamine-Regulated Transcript (CART), chromogranin A, and chromogranin B in neuroendocrine tumor diagnosis and assessment of disease progression.

B. Khoo, N. Martin, S. Bloom, 2015, The Journal of clinical endocrinology and metabolism.

Clinical and Laboratory Findings in Twins with Neonatal Epileptic Encephalopathy Mimicking Aromatic L-Amino Acid Decarboxylase Deficiency

R. Wevers, G. Hoffmann, C. Bräutigam, 2002, Neuropediatrics.

Aromatic L-Amino Acid Decarboxylase Deficiency with Hyperdopaminuria. Clinical and Laboratory Findings in Response to Different Therapies

L. Lagae, R. Wevers, G. Hoffmann, 2002, Neuropediatrics.

The influence of L-dopa on methylation capacity in aromatic L-amino acid decarboxylase deficiency: Biochemical findings in two patients

R. Wevers, G. Hoffmann, C. Bräutigam, 2000, Journal of Inherited Metabolic Disease.

Infantile parkinsonism-dystonia and elevated dopamine metabolites in CSF

R. Robinson, R. Surtees, R. Wevers, 2004, Neurology.

N-acetyl-L-leucine improves symptoms and functioning in GM2 Gangliosidosis (Tay-Sachs & Sandhoff)

J. Claassen, S. Perlman, J. Gascón-Bayarri, 2021, medRxiv.

Aromatic l-amino acid decarboxylase deficiency

D. Vivo, C. Chiriboga, R. Pons, 2004, Neurology.

Neuroendocrine tumors and CUP

A. Carrato, M. Kudo, R. Salazar, 2012 .